Abstract
Burn care management includes assessing the severity of burns accurately, especially distinguishing superficial partial thickness (SPT) burns from deep partial thickness (DPT) burns, in the context of providing definitive, downstream treatment. Moreover, the healing of the wound in the sub-acute care setting requires continuous tracking to avoid complications. Artificial intelligence (AI) and computer vision (CV) provide a unique opportunity to build low-cost and accessible tools to classify burn severity and track changes of wound parameters, both in the clinic by physicians and nurses, and asynchronously in the remote setting by the patient themselves. Wound assessments can be achieved by AI-CV using the principles of Image-Guided Therapy (IGT) using high-quality 2D colour images. Wound parameters can include wound 2D spatial dimension and the characterization of wound colour changes which demonstrates physiological changes such as presentation of eschar/necrotic tissue, pustulence, granulation tissue and scabbing. Here we present the development of AI-CV-based Skin Abnormality Tracking Algorithm (SATA) pipeline. Additionally we provide proof-of-concept results on a severe localized burn tracked for a 6-week period in clinic, and an additional 2-week period of home monitoring.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partially funded by National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) and the Mitacs program, Canada
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Health Research Ethics Board-Health Panel,Alberta and the National Research Council(NRC) Research Ethics Board(NRC-REB), Canada, gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
